Delivery Order SPE2DB20D9331-SPE2DB25FL1D4

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $116K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $91,598.40 contract is for the delivery of Cabometyx 20 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,443.96 firm fixed-price delivery order is for the supply of Cabometyx 40 mg tablets. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a...
This federal contract award, valued at $16,434.34, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order contract is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 4, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,221.97 contract was awarded by the Defense Logistics Agency (DLA) to supply the drug CABOMETYX 40 MG TABLET 30S. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $33,265.08, is for the delivery of 20 mg Cabometyx tablets over a period ending on January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,221.97 firm fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order, contract SPE2DB24FSW72, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,409.02 order is for the supply of Cabometyx 40 mg tablets. This delivery order is part of a larger indefinite-delivery vehicle (IDV), contract SPE2DB22D9367, with DMS Pharmaceutical Group that has a ceiling value of up to $4,999,999 through 2025. The IDV allows DLA to issue delivery...
The Department of Defense (DoD) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $15,409.02, is for the delivery of Cabometyx 40 mg tablets to meet the recurring pharmaceutical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,818.04, is for the delivery of 4564600789 CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through May 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cabometyx 40 mg tablets in 30-count packages, with a ceiling value of $30,818.04 and a period of performance through April 30, 2024. The contract is a delivery order under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1D4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $116,427.78, is for the delivery of the prescription drug Cabometyx 20 mg tablets. The contract is a firm fixed-price delivery order, without any set-aside designation, and has an ultimate completion date of May 1, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide.

Generated 8/3/25, 1:30 AM